206 related articles for article (PubMed ID: 8188460)
1. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.
Pepose JS; Leib DA
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2662-6. PubMed ID: 8188460
[No Abstract] [Full Text] [Related]
2. Replication-defective genomic herpes simplex vectors: design and production.
Burton EA; Bai Q; Goins WF; Glorioso JC
Curr Opin Biotechnol; 2002 Oct; 13(5):424-8. PubMed ID: 12459332
[TBL] [Abstract][Full Text] [Related]
3. Generation of replication-competent and -defective HSV vectors.
Goins WF; Krisky DM; Wechuck JB; Wolfe D; Huang S; Glorioso JC
Cold Spring Harb Protoc; 2011 May; 2011(5):pdb.prot5615. PubMed ID: 21536761
[TBL] [Abstract][Full Text] [Related]
4. Gene delivery to neurons: is herpes simplex virus the right tool for the job?
Leib DA; Olivo PD
Bioessays; 1993 Aug; 15(8):547-54. PubMed ID: 8135768
[TBL] [Abstract][Full Text] [Related]
5. Replication-defective herpes simplex virus vectors for gene transfer in vivo.
Marconi P; Krisky D; Oligino T; Poliani PL; Ramakrishnan R; Goins WF; Fink DJ; Glorioso JC
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11319-20. PubMed ID: 8876133
[No Abstract] [Full Text] [Related]
6. Construction of multiply disabled herpes simplex viral vectors for gene delivery to the nervous system.
Lilley CE; Coffin RS
Methods Mol Med; 2003; 76():33-49. PubMed ID: 12526157
[No Abstract] [Full Text] [Related]
7. Development and application of herpes simplex virus vectors for human gene therapy.
Glorioso JC; DeLuca NA; Fink DJ
Annu Rev Microbiol; 1995; 49():675-710. PubMed ID: 8561476
[TBL] [Abstract][Full Text] [Related]
8. Gene delivery using herpes simplex virus vectors.
Burton EA; Fink DJ; Glorioso JC
DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
[TBL] [Abstract][Full Text] [Related]
9. Construction of replication-defective herpes simplex virus vectors.
Goins WF; Marconi P; Krisky D; Wolfe D; Glorioso JC; Ramakrishnan R; Fink DJ
Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.11. PubMed ID: 18428322
[TBL] [Abstract][Full Text] [Related]
10. Genetically engineered herpes simplex viral vectors in the treatment of brain tumors: a review.
Aghi M; Chiocca EA
Cancer Invest; 2003 Apr; 21(2):278-92. PubMed ID: 12743992
[No Abstract] [Full Text] [Related]
11. Herpes simplex virus type 1-based amplicon vector systems.
Fraefel C; Jacoby DR; Breakefield XO
Adv Virus Res; 2000; 55():425-51. PubMed ID: 11050950
[No Abstract] [Full Text] [Related]
12. Gene transfer to neurons using herpes simplex virus-based vectors.
Fink DJ; DeLuca NA; Goins WF; Glorioso JC
Annu Rev Neurosci; 1996; 19():265-87. PubMed ID: 8833444
[TBL] [Abstract][Full Text] [Related]
13. Ocular gene therapy: experimental studies and clinical possibilities.
Murata T; Kimura H; Sakamoto T; Osusky R; Spee C; Stout TJ; Hinton DR; Ryan SJ
Ophthalmic Res; 1997; 29(5):242-51. PubMed ID: 9323715
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ocular disorders by gene therapy.
Solinís MÁ; del Pozo-Rodríguez A; Apaolaza PS; Rodríguez-Gascón A
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):331-42. PubMed ID: 25536112
[TBL] [Abstract][Full Text] [Related]
15. Use of the herpes simplex viral genome to construct gene therapy vectors.
Burton EA; Huang S; Goins WF; Glorioso JC
Methods Mol Med; 2003; 76():1-31. PubMed ID: 12526156
[No Abstract] [Full Text] [Related]
16. Herpes simplex virus type 1 (HSV-1)-derived amplicon vectors for gene transfer and gene therapy.
Fraefel C; Marconi P; Epstein AL
Methods Mol Biol; 2015; 1254():295-316. PubMed ID: 25431073
[TBL] [Abstract][Full Text] [Related]
17. B-50/GAP-43 expression via a defective herpes simplex virus vector results in persistent morphological changes in non-neuronal cells.
Verhaagen J; Hermens WT; Kaplitt MG; Pfaff DW; Gispen WH
Gene Ther; 1994; 1 Suppl 1():S81. PubMed ID: 8542427
[No Abstract] [Full Text] [Related]
18. Herpes simplex amplicon vectors.
Link CJ; Vahanian NN; Wang S
Methods Mol Med; 2003; 76():61-87. PubMed ID: 12526159
[No Abstract] [Full Text] [Related]
19. No false start for novel pseudotyped vectors.
Sanders DA
Curr Opin Biotechnol; 2002 Oct; 13(5):437-42. PubMed ID: 12459334
[TBL] [Abstract][Full Text] [Related]
20. LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector.
Huard J; Akkaraju G; Watkins SC; Pike-Cavalcoli M; Glorioso JC
Hum Gene Ther; 1997 Mar; 8(4):439-52. PubMed ID: 9054519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
